Key Drivers
- Margin Expansion
- Cash Flow
- Debt Pressure
AIAI Summary
FUL is increasingly a margin-and-portfolio execution story—not a volume recovery story—as pricing, mix, and the AMS medical-adhesives deal are improving earnings and cash flow, but soft end markets and ~4x pro forma leverage mean upside depends on clean integration and sustained price/cost discipline rather than demand rebound.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Cash Flow
- •Debt Pressure
FUL's margins and cash flow improved meaningfully, but heavy leverage, intangible-heavy assets, and only moderate valuation keep the risk/reward balanced.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support holding
- •Resistance overhead
FUL has been in a clear downtrend over the last month, with lower highs and a drop below $60, while buyers are only now emerging around $57.28-$58.06, making the setup mixed to negative unless it reclaims $60-$63.25.
After peaking at $64.86, price slid in a steady pullback and recently stabilized near support
Sentiment & News
Key News Insights:
- •Earnings Beat
- •Margin Expansion
- •Medical Adhesives
H.B. Fuller posted a solid Q2 earnings beat with improving margins and cash generation, while its recommended acquisition of Advanced Medical Solutions adds strategic growth potential despite some deal opposition. #M&A
The quarter and acquisition news are broadly supportive for FUL, but near-term stock performance will likely depend on integration execution and how the market values the deal
Similar Companies in Basic Materials
Other companies in the same sector with AI ratings